BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3022444)

  • 21. Human monoclonal antibodies to a genus-specific chlamydial antigen, produced by EBV-transformed B cells.
    Rosén A; Persson K; Klein G
    J Immunol; 1983 Jun; 130(6):2899-902. PubMed ID: 6189902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus in rheumatoid arthritis.
    Fox RI; Lotz M; Rhodes G; Vaughan JH
    Clin Rheum Dis; 1985 Dec; 11(3):665-88. PubMed ID: 3000687
    [No Abstract]   [Full Text] [Related]  

  • 23. Transformation of nonhuman primate lymphocytes by Epstein-Barr virus.
    Deinhardt F; Falk LA; Wolfe LG
    Cancer Res; 1974 May; 34(5):1241-4. PubMed ID: 4367158
    [No Abstract]   [Full Text] [Related]  

  • 24. EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes.
    Zimber-Strobl U; Strobl LJ
    Semin Cancer Biol; 2001 Dec; 11(6):423-34. PubMed ID: 11669604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of Epstein-Barr virus with leukaemic B cells in vitro. I. Abortive infection and rare cell line establishment from chronic lymphocytic leukaemic cells.
    Rickinson AB; Finerty S; Epstein MA
    Clin Exp Immunol; 1982 Nov; 50(2):347-54. PubMed ID: 6295671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human B lymphocytes activated by Epstein-Barr virus (EBV) or by mitogens suppress mitogen-induced immunoglobulin production.
    Tsukuda K; Berczi I; Klein G
    J Immunol; 1981 May; 126(5):1810-3. PubMed ID: 6260858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro growth of B lymphocytes infiltrating human melanoma tissue by transformation with EBV: evidence for secretion of anti-melanoma antibodies by some transformed cells.
    Watson DB; Burns GF; Mackay IR
    J Immunol; 1983 May; 130(5):2442-7. PubMed ID: 6300247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein Barr virus.
    Brown NA; Miller G
    J Immunol; 1982 Jan; 128(1):24-9. PubMed ID: 6274955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of the functional capabilities of human neonatal lymphocytes for in vitro specific antibody production.
    Yarchoan R; Nelson DL
    J Immunol; 1983 Sep; 131(3):1222-8. PubMed ID: 6309961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. J chain deficiency in human IgM monoclonal antibodies produced by Epstein-Barr virus-transformed B lymphocytes.
    Meng YG; Criss AB; Georgiadis KE
    Eur J Immunol; 1990 Nov; 20(11):2505-8. PubMed ID: 2174785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of suppressor T cells by autologous lymphoblastoid cells: a mechanism for feedback regulation of immunoglobulin synthesis.
    James SP; Yenokida GG; Graeff AS; Strober W
    J Immunol; 1982 Mar; 128(3):1149-54. PubMed ID: 6276467
    [No Abstract]   [Full Text] [Related]  

  • 32. The B cell surface molecule B1 is functionally linked with B cell activation and differentiation.
    Tedder TF; Boyd AW; Freedman AS; Nadler LM; Schlossman SF
    J Immunol; 1985 Aug; 135(2):973-9. PubMed ID: 3925015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of Epstein-Barr virus to transform fetal human spleen cells for HLA typing.
    Mandel TE; Tait BD
    Transplantation; 1984 Oct; 38(4):436-7. PubMed ID: 6093295
    [No Abstract]   [Full Text] [Related]  

  • 34. Expression of the IL-6 gene induces differentiation of a human monoclonal EBV-transformed B cell line.
    Jochems GJ; Bende RJ; Klein MR; Zeijlemaker WP; van Lier RA
    Hum Antibodies Hybridomas; 1993 Jul; 4(3):124-33. PubMed ID: 8395233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Production of human monoclonal antibodies by Epstein-Barr virus-transformed cell lines].
    Avital A; Steinitz M
    Harefuah; 1984 Oct; 107(7-8):167-8. PubMed ID: 6097516
    [No Abstract]   [Full Text] [Related]  

  • 36. Human monoclonal antibodies isolated from spontaneous Epstein-Barr virus-transformed tumors of Hu-SPL-SCID mice and specific for fusion protein display broad neutralizing activity toward respiratory syncytial virus.
    Chamat S; Walsh EE; Anderson D; Osta M; Awaraji C; Pan LZ; Ochi J; Shuey S; Brams P
    J Infect Dis; 1999 Aug; 180(2):268-77. PubMed ID: 10395839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human monoclonal antibodies to viral peptides.
    Sidorova E; Borisova T; Lyakisheva L; Rosen A
    Hum Antibodies; 1997; 8(2):65-9. PubMed ID: 9289390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
    Klein G; Ehlin-Henriksson B; Schlossman SF
    J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus transformation of human pre-B cells.
    Hansson M; Falk K; Ernberg I
    J Exp Med; 1983 Aug; 158(2):616-22. PubMed ID: 6310019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Manipulation of human B cells to confer immortality.
    Jonak ZL; Henri E; Trulli S; Jensen CP; Muirhead KA
    Hum Antibodies Hybridomas; 1992 Oct; 3(4):177-85. PubMed ID: 1335787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.